AUTUMN BEASLEY: Open Payments
NPI 1699075960 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$770 in 56 payments from 10 companies in 2025. Trend: 2023 $865 · 2024 $938 · 2025 $770
Food & beverage: $770
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 29 | $323 |
| UCB, Inc. | 15 | $225 |
| Actelion Pharmaceuticals US, Inc. | 3 | $47 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
| Janssen Biotech, Inc. | 1 | $36 |
| ABBVIE INC. | 2 | $34 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Radius Health, Inc. | 1 | $18 |
| GENZYME CORPORATION | 1 | $14 |
| Organon LLC | 1 | $12 |
Products named: Bimzelx, TAVNEOS, KRYSTEXXA, OPSYNVI, EVENITY, OFEV, TREMFYA, OTEZLA.
Industry payments across TX — which companies pay providers there.
